Isis Pharmaceuticals, Inc. Form 10K - page 116

F-28
StockOptionActivity
The following table summarizes the stock option activity for the year endedDecember 31, 2013 (in thousands, except per
share and contractual life data):
Number of
Shares
Weighted
AverageExercise
Price
PerShare
Average
Remaining
Contractual Term
Aggregate
Intrinsic
Value
(Years)
Outstanding atDecember 31, 2012 .........................
10,823 $
11.30
Granted ...............................................................
1,911 $
15.88
Exercised .............................................................
(5,216) $
11.89
Cancelled/forfeited/expired .................................
(239) $
11.19
Outstanding atDecember 31, 2013 .........................
7,279 $
12.08
4.28 $
202,078
Exercisable atDecember 31, 2013 ..........................
3,948 $
11.52
3.13 $
111,685
Theweighted-average estimated fair values of options grantedwere $7.10, $3.55 and $4.85 for the years endedDecember 31,
2013, 2012 and2011, respectively. The total intrinsic value of options exercisedduring the years endedDecember 31, 2013, 2012 and
2011were $69.6million, $7.6million and$686,000, respectively, whichwe determined as of the date of exercise. The amount of cash
received from the exercise of stock optionswas $62.0million, $8.7million and$2.8million for the years endedDecember 31, 2013,
2012 and 2011, respectively. For the year endedDecember 31, 2013, theweighted-average fair value of options exercisedwas $25.24.
As ofDecember 31, 2013, total unrecognized compensation cost related tonon-vested stock-based compensation planswas $9.6
million.Wewill adjust the total unrecognized compensation cost for future changes in estimated forfeitures.We expect to recognize
this cost over aweighted average periodof 1.1 years.
RestrictedStockUnitActivity
The following table summarizes the restricted stock unit, or RSU, activity for the year endedDecember 31, 2013 (in
thousands, except per share data):
Number of
Shares
Weighted
Average
GrantDate
FairValue
Per Share
Non-vested atDecember 31, 2012 ...............................................
188 $
8.37
Granted .....................................................................................
297 $
17.42
Vested .......................................................................................
(47) $
16.64
Cancelled/forfeited ...................................................................
(13) $
11.78
Non-vested atDecember 31, 2013 ...............................................
425 $
13.67
For the years endedDecember 31, 2013 and2012, theweighted-average grant date fair value of RSUs granted to employees
was $16.94 and$8.22per RSU, respectively, and theweighted-average grant date fair value of RSUs granted toour Boardof
Directorswas $27.95 and $12.94 per RSU, respectively. As ofDecember 31, 2013, total unrecognized compensation cost related to
RSUswas $3.5million.Wewill adjust the total unrecognized compensation cost for future changes in estimated forfeitures.We
expect to recognize this cost over aweighted average period of 1.5 years.
I...,106,107,108,109,110,111,112,113,114,115 117,118,119,120,121,122,123,124,125,126,...134
Powered by FlippingBook